← Browse by Condition
Medical Condition
back pain
Total Trials
9
Recruiting Now
9
Trial Phases
Phase 1, EARLY_Phase 1, Phase 3
Pain clinical trials span acute procedural pain, chronic musculoskeletal pain, neuropathic pain, and cancer-related pain β€” each requiring distinct trial designs and patient-reported outcome instruments. The regulatory demand for non-opioid alternatives has intensified the search for novel analgesic mechanisms, particularly ion channel targets and neurostimulation approaches.
Active trials evaluate Nav1.7/1.8 blockers, CGRP antagonists for new indications, spinal cord stimulation refinements, virtual reality-based pain management, and patient-specific ketamine infusion protocols. Pain trials increasingly use ecological momentary assessment (EMA) diary approaches over traditional recall-based pain rating scales.
Frequently Asked Questions — back pain Clinical Trials
How many clinical trials are currently recruiting for back pain?
ClinicalMetric currently tracks 9 actively recruiting clinical trials for back pain, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 9. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for back pain?
back pain research spans Phase 1 (2 trials), Phase 3 (1 trial), Phase 4 (2 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a back pain clinical trial?
Eligibility criteria for back pain trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1 2
Phase 3 1
Phase 4 2
Top Sponsors
1 trial
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT07528833
Recruiting
Enrollment
120 pts
Location
Finland
Sponsor
Tampere University Hospital
NCT07579182 Phase 1
Recruiting
Enrollment
140 pts
Location
United States
Sponsor
University of Houston
NCT04982965 EARLY_Phase 1
Recruiting
Enrollment
100 pts
Location
United States
Sponsor
University of California, San ...
NCT06027099 Phase 3
Recruiting
Enrollment
375 pts
Location
United States
Sponsor
Stanford University
NCT05953155
Recruiting
Enrollment
110 pts
Location
Brazil
Sponsor
Federal University of Minas Ge...
NCT07588490
Recruiting
Enrollment
222 pts
Location
Belgium
Sponsor
Cliniques universitaires Saint...
NCT07112404
Recruiting
Enrollment
42 pts
Location
United States
Sponsor
The University of Texas Medica...
NCT06395428 Phase 4
Recruiting
Enrollment
75 pts
Location
United States
Sponsor
Western Michigan University Sc...
NCT07632820 Phase 4
Recruiting
Enrollment
76 pts
Location
United States
Sponsor
Mayo Clinic
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology